This is a federal contract award to Cepheid, a for-profit manufacturer of molecular diagnostic solutions, by the Defense Logistics Agency (DLA) for the supply of XPRSARS-COV2-DOD diagnostic systems, reagents, and test kits. The $12,705.00 firm fixed-price delivery order contract has an ultimate completion date of February 3, 2025. Cepheid is the prime contractor and there is no set-aside designation for this award. The contract is part of a larger Indefinite Delivery Vehicle (IDV) held by...
This federal contract award was made by the Defense Logistics Agency (DLA) to Cepheid, a for-profit manufacturer of molecular diagnostic solutions based in Sunnyvale, California. The $1,500.00 firm fixed-price delivery order contract is for the provision of XPRSARS-COV2-DOD, which appears to be a COVID-19 diagnostic product. The contract has a ceiling value of $1,500.00 and a period of performance through May 20, 2025. No set-aside designation is mentioned. Cepheid is an experienced federal...
This is a federal contract award to Cepheid, a for-profit manufacturer of molecular diagnostic solutions based in Sunnyvale, California. The $4,039.65 firm fixed-price delivery order contract was awarded by the U.S. Department of Defense's Medical Supply Chain agency on May 16, 2025, with a completion date of May 23, 2025. The contract does not have a set-aside designation. Cepheid is an experienced federal contractor, holding several significant Indefinite Delivery Vehicle (IDV) contracts...
This is a federal contract award to Cepheid, a for-profit manufacturer of molecular diagnostic solutions, by the Defense Logistics Agency (DLA), a component of the U.S. Department of Defense. The award, valued at $1,054.20, is a firm fixed-price delivery order contract with no set-aside designation. The contract requires Cepheid to provide the DLA with its GeneXpert diagnostic systems, molecular reagents, test kits, and associated maintenance services. These solutions are used to detect a...
This is a federal contract award to Cepheid, a for-profit manufacturer of molecular diagnostic solutions, for the provision of SARS-COV-2/FLU PCR testing products and services. The contract, valued at $733,519.78, is a firm fixed-price delivery order awarded by the Defense Health Agency, a defense agency, and has an ultimate completion date of September 30, 2024. The contract does not have a set-aside designation. Cepheid is the prime contractor and is registered in the System for Award...
This is a federal contract award to Cepheid, a for-profit manufacturer of molecular diagnostic solutions, by the Medical Supply Chain agency within the U.S. Department of Defense. The $8,228.00 firm fixed-price delivery order is for XPCOV2/FLU/RSV-10 products, which are likely COVID-19, influenza, and respiratory syncytial virus (RSV) diagnostic tests and related equipment. Cepheid is a prime contractor that has been awarded multiple federal contracts and grants, including a $5,000,000...
This is a federal contract award to Cepheid, a for-profit manufacturer of molecular diagnostic solutions, by the Defense Logistics Agency, a component of the Department of Defense. The contract, valued at $1,500.00, is a firm fixed-price delivery order with no set-aside designation. Cepheid will provide molecular diagnostic testing solutions, including GeneXpert diagnostic systems, reagents, test kits, and maintenance services, to support the detection of infectious diseases such as COVID-19,...
The U.S. Department of Defense's Medical Supply Chain agency has awarded a $1,104.00 firm fixed-price delivery order contract to Cepheid, a for-profit manufacturer of molecular diagnostic solutions. The contract has an ultimate completion date of April 12, 2024 and was awarded on April 5, 2024. This contract does not have a set-aside designation. Cepheid is an experienced federal contractor, holding several indefinite delivery contracts with the Department of Veterans Affairs to provide...
The U.S. government awarded a firm fixed-price delivery order contract worth $1,970.00 to Cepheid, a for-profit manufacturer of molecular diagnostic solutions, including tests for infectious diseases and genetic conditions. The contract was awarded by the Medical Supply Chain, a component of the Defense agency, and has an ultimate completion date of January 7, 2025. Cepheid has been awarded numerous federal contracts and indefinite delivery vehicles to provide diagnostic testing equipment,...
This is a federal contract award to Cepheid, a for-profit manufacturer of molecular diagnostic solutions, by the Defense Logistics Agency (DLA). The contract is a delivery order worth $4,539.30 with a firm fixed price pricing type and an ultimate completion date of April 18, 2025. Cepheid, the prime contractor, will provide molecular diagnostic testing solutions, including GeneXpert diagnostic systems, reagents, test kits, and maintenance services, to support the detection of infectious diseases...